COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
nippon india pharma fund - growth
Nippon India Pharma Fund - Growth

Nippon India Pharma Fund - Growth

  • Very High Risk
  • Equity
  • Sector - Healthcare
Share
  • Whatsapp
  • Twitter
  • Facebook
NAV as on Aug 4, 2025
i
Price per unit of the scheme.
517.46760.13%1 Day Change
-1.01%
Minimum Investment₹5000
Expense Ratio1.91%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions
 

bt_logoFUND PERFORMANCE

As On Jan 01, 2023
Compare fund’s performance against category average across different time periods


No Data Found.
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

bt_logoFUND COMPARISON



No Data Found.
*For the other fund, rescaled NAVs are used
Share
  • Whatsapp
  • Twitter
  • Facebook

bt_logoRETURN CALCULATOR

Check the return on your investment in the fund
Nippon India Pharma Fund - Growth
Investment Type
Monthly Investment
Time Period (yrs)
Annual Return in %
  • Invested Amount
    0
  • Return
    0
  • Current Value
    0

bt_logoFUND MANAGER

Sailesh Raj Bhan
Sailesh Raj Bhan
i
Lead Fund Manager.
Apr 1, 2005 - Present
  • Fund Manager Rank8Out of 10
    i
    Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
  • Schemes managed3
  • Total AUM97,763.84 Cr
  • Highest Return In 1 Yr5.80 %
Other Funds
  • table
  • card
1M
3M
6M
1Y
3Y
5Y
Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
--
₹ 576.61
-0.93%
-0.45%
Very High Risk
8,569.15Cr
₹ 327.69
-0.73%
-2.33%
Very High Risk
45,366.09Cr
₹ 100.28
-1.48%
-2.52%
Very High Risk
43,828.60Cr
Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk--
  • NAV₹ 576.61
  • Fund Size8,569.15Cr
Fund Return-0.93%
Category Return-0.45%
Nippon India Multi Cap Fund - Direct Plan - Growth
Very High Risk
  • NAV₹ 327.69
  • Fund Size45,366.09Cr
Fund Return-0.73%
Category Return-2.33%
Nippon India Large Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV₹ 100.28
  • Fund Size43,828.60Cr
Fund Return-1.48%
Category Return-2.52%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
Kinjal Desai
Kinjal Desai
i
Lead Fund Manager.
May 25, 2018 - Present
  • Schemes managed52
  • Total AUM4,36,516.68 Cr
  • Highest Return In 1 Yr340.03 %
Other Funds
  • table
  • card
1M
3M
6M
1Y
3Y
5Y
Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
₹ 189.22
-2.64%
-2.81%
Very High Risk
66,601.80Cr
₹ 39.02
0.95%
0.55%
High Risk
1,018.01Cr
--
₹ 576.61
-0.93%
-0.45%
Very High Risk
8,569.15Cr
Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV₹ 189.22
  • Fund Size66,601.80Cr
Fund Return-2.64%
Category Return-2.81%
Nippon India Credit Risk Fund Direct Plan Growth Option
High Risk
  • NAV₹ 39.02
  • Fund Size1,018.01Cr
Fund Return0.95%
Category Return0.55%
Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk--
  • NAV₹ 576.61
  • Fund Size8,569.15Cr
Fund Return-0.93%
Category Return-0.45%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
Akshay Sharma
Akshay Sharma
i
Lead Fund Manager.
Dec 1, 2022 - Present
  • Schemes managed51
  • Total AUM4,36,510.51 Cr
  • Highest Return In 1 Yr340.03 %
Other Funds
  • table
  • card
1M
3M
6M
1Y
3Y
5Y
Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
--
₹ 576.61
-0.93%
-0.45%
Very High Risk
8,569.15Cr
₹ 189.22
-2.64%
-2.81%
Very High Risk
66,601.80Cr
₹ 198.88
-0.88%
-1.73%
High Risk
9,390.89Cr
Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk--
  • NAV₹ 576.61
  • Fund Size8,569.15Cr
Fund Return-0.93%
Category Return-0.45%
Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV₹ 189.22
  • Fund Size66,601.80Cr
Fund Return-2.64%
Category Return-2.81%
Nippon India Balanced Advantage Fund Direct Growth Plan
High Risk
  • NAV₹ 198.88
  • Fund Size9,390.89Cr
Fund Return-0.88%
Category Return-1.73%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

bt_logoDETAILED PORTFOLIO

As on Jun, 2025
EQUITY (99.47%)
DEBT (-%)
CASH (0.53%)
Allocation by Market Cap
Large Cap(35.06%)
Mid Cap(31.99%)
Small Cap(32.41%)
Industry Holdings
  • Drug Manufacturers Specialty Generic62.98%
  • Diagnostics Research12.24%
  • Medical Care10.11%
  • Drug Manufacturers Major8.92%
  • Pharmaceutical Retailers New3.85%
  • Biotechnology1.89%
Stock Holdings
  • Sun Pharmaceuticals Industries Ltd12.23%
  • Divi's Laboratories Ltd8.50%
  • Lupin Ltd6.07%
  • Cipla Ltd5.62%
  • Apollo Hospitals Enterprise Ltd5.48%
  • Dr Reddy's Laboratories Ltd5.18%

bt_logoPERFORMANCE MEASURES

Fund evaluation across critical parameters for better decision making. Study period is 3 years.
  • Consistency
    i
    It represents the consistency of a fund in beating its benchmark.
    ----
  • Downside Risk
    i
    Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
    ----
  • Risk Adjusted Return
    i
    Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
    ----
  • Volatility
    i
    Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
    ----
  • Upside Capture Ratio
    i
    Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
    ----
  • Downside Capture Ratio
    i
    Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.
    ----

bt_logoHISTORICAL RISK MEASURES

Statistical measures to evaluate mutual fund risk. All ratios are calculated for a three-year time duration.
  • Alpha: Excess return of the fund over benchmark
    i
    Any Alpha above zero is considered good. However, for comparison, a fund with a higher Alpha is considered better. Alpha is normally used in conjunction with Beta. If the Beta is high, it implies that the fund manager took a high risk to generate Alpha.
    0.72
    This Fund
    VS
    -0.07
    Category Avg
  • R-Squared: How well the fund tracks benchmark
    i
    R-Squared measures the correlation of fund returns and its benchmark returns. It varies between 0 and 1. The metric, Beta makes no sense if R-Squared is equal to zero. Thus, both Beta and R-Squared should be used in conjunction. A fund with a high R-Squared and low Beta is considered a less risky fund.
    94.39
    This Fund
    VS
    94.29
    Category Avg
  • Beta: Risk of the fund in relation to benchmark
    i
    Beta >1 indicates that the fund is more volatile than its benchmark while Beta < 1 indicates that the fund is less volatile than its benchmark. The Beta of the benchmark is equal to 1.
    0.90
    This Fund
    VS
    0.96
    Category Avg
  • Sharpe Ratio: Risk adjusted return of the fund
    i
    Sharpe Ratio is a measure of return per unit of risk. A higher Sharpe ratio indicates better risk adjusted return given by the fund.
    1.14
    This Fund
    VS
    1.09
    Category Avg
  • Sortino Ratio: Return per unit of bad risk
    i
    A variation of Sharpe ratio, Sortino considers only the downside risk. Unlike Sharpe ratio which considers both good risk and bad risk, Sortino factors only the bad risk. A high Sortino ratio indicates better return for each unit of downside risk.
    2.08
    This Fund
    VS
    1.99
    Category Avg
  • Standard Devation: Volatility of the fund
    i
    Standard deviation is a measure of dispersion of fund returns from its average return. A fund with a higher Standard deviation is more volatile than a fund with a low standard deviation.
    14.62
    This Fund
    VS
    15.60
    Category Avg
Benchmark used in calculation : S&P BSE 500 India TR INR

bt_logoPEER ANALYSIS

1M
3M
6M
1Y
3Y
5Y
  • card
  • table
Fund NameMorningstar RatingNAV Fund Return Category ReturnRisk Fund Size
--
₹ 29.61
1.24%
-0.45%
Very High Risk
₹ 87.70 Cr
--
₹ 39.51
0.70%
-0.45%
Very High Risk
₹ 3,056.90 Cr
--
₹ 292.12
0.57%
-0.45%
Very High Risk
₹ 1,098.70 Cr
--
₹ 31.17
0.55%
-0.45%
Very High Risk
₹ 840.48 Cr
--
₹ 40.23
0.40%
-0.45%
Very High Risk
₹ 5,727.59 Cr
--
₹ 434.72
0.22%
-0.45%
Very High Risk
₹ 3,849.24 Cr
IDBI Healthcare Fund Regular Growth
Very High Risk--
  • NAV₹ 29.61
  • Fund Size₹ 87.70 Cr
Fund Return1.24%
Category Return-0.45%
DSP Healthcare Fund Regular Growth
Very High Risk--
  • NAV₹ 39.51
  • Fund Size₹ 3,056.90 Cr
Fund Return0.70%
Category Return-0.45%
UTI Healthcare Fund Regular Plan Growth
Very High Risk--
  • NAV₹ 292.12
  • Fund Size₹ 1,098.70 Cr
Fund Return0.57%
Category Return-0.45%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
Very High Risk--
  • NAV₹ 31.17
  • Fund Size₹ 840.48 Cr
Fund Return0.55%
Category Return-0.45%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Very High Risk--
  • NAV₹ 40.23
  • Fund Size₹ 5,727.59 Cr
Fund Return0.40%
Category Return-0.45%
SBI Healthcare Opportunities Fund Regular Growth
Very High Risk--
  • NAV₹ 434.72
  • Fund Size₹ 3,849.24 Cr
Fund Return0.22%
Category Return-0.45%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

bt_logoTOP FUNDS FROM THIS AMC

1M
3M
6M
1Y
3Y
5Y
  • card
  • table
Fund NameMorningstar RatingNAV Fund Return Category Return Risk Fund Size (Cr)
Nippon India Credit Risk Fund Segregated Portfolio 1 Direct Growth
High Risk--
  • NAV₹ 0.53
  • Fund Size₹ 23.68 Cr
1 Month Return298.36%
Category Return--
Nippon India Strategic Debt Fund Segregated Portfolio 1 Direct Growth
Very High Risk--
  • NAV₹ 0.19
  • Fund Size₹ 6.16 Cr
1 Month Return297.89%
Category Return--
Nippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Growth Option
Moderate Risk--
  • NAV₹ 0.68
  • Fund Size₹ 25.81 Cr
1 Month Return126.02%
Category Return--
Nippon India Equity Savings Segregated Portfolio 1 Direct Plan Growth Plan Bonus Option
Moderate Risk--
  • NAV₹ 0.68
  • Fund Size₹ 25.81 Cr
1 Month Return126.02%
Category Return--
Nippon India Equity Hybrid Fund Segregated Portfolio 1 Direct Plan Growth Plan
Very High Risk--
  • NAV₹ 0.13
  • Fund Size₹ 9.33 Cr
1 Month Return125.99%
Category Return--
Nippon India Silver ETF Fund of Fund (FOF) Direct Growth
Very High Risk--
  • NAV₹ 17.41
  • Fund Size₹ 863.64 Cr
1 Month Return4.00%
Category Return3.31%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

bt_logoABOUT THE AMC

company icon
Nippon Life India Asset Management Ltd
Nippon Life India Asset Management Ltd manages assets worth ₹ 6,52,947.28 crores. It’s current offering of mutual fund schemes includes 33 equity, 78 debt and 13 hybrid schemes.
phone icon
Phone
022-6808 7000/18602660111
mail icon
Email
customercare@nipponindiaim.in
aum
AUM
6,52,947.28 Cr (
As on Jun 30, 2025
)
location
Address
4th Floor, Tower A, Peninsula Business Park, Mumbai,400 013

bt_logoFAQ's

What is the category of Nippon India Pharma Fund - Growth ?
The category of Nippon India Pharma Fund - Growth is Equity - Sector - Healthcare
What is the current NAV of Nippon India Pharma Fund - Growth ?
The current NAV of Nippon India Pharma Fund - Growth as on Aug 04, 2025 is ₹517.47
How safe is Nippon India Pharma Fund - Growth ?
The risk level of Nippon India Pharma Fund - Growth is Very High.
What are short term returns given by Nippon India Pharma Fund - Growth ?
The return given by Nippon India Pharma Fund - Growth in 1 month is -1.01%, 3 months is 4.82%, 6 months is 6.27%, and 1 year is 4.84%
What are the long term returns given by Nippon India Pharma Fund - Growth ?
The return given by Nippon India Pharma Fund - Growth in 3 years is 22.92% and 5 years is 19.37%.
What is the expense ratio of Nippon India Pharma Fund - Growth ?
The expense ratio of Nippon India Pharma Fund - Growth is 1.91%
What is the AUM of Nippon India Pharma Fund - Growth ?
The assets under Management (AUM) of Nippon India Pharma Fund - Growth is Rs 8,569.15 crores.
What is the minimum investment in Nippon India Pharma Fund - Growth ?
The minimum Lumpsum investment in Nippon India Pharma Fund - Growth is ₹5,000.00 and the minimum SIP investment in Nippon India Pharma Fund - Growth is ₹100.00
What is the asset allocation of Nippon India Pharma Fund - Growth?
Nippon India Pharma Fund - Growth has an exposure of 99.47% in Equity and 0.53% in Cash & Money Market Securities